Market Closed -
Japan Exchange
07:00:00 08/05/2024 BST
5-day change
1st Jan Change
2,580
JPY
-3.26%
-2.99%
+11.62%
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million.
The company closed its plan on March 8, 2024.
Penumbra, Inc. : The underdog in healthcare
04-12
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation
03-17
CI
Jefferies Adjusts Terumo’s Price Target to 6,700 Yen From 5,300 Yen, Keeps at Buy
03-13
MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.
03-11
CI
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million.
03-07
CI
Terumo Repurchases 521 Million Yen Shares in February
03-05
MT
Terumo Corp to Undertake One-to-Two Share Split
02-08
MT
Terumo's Attributable Profit Climbs 13.8% in Fiscal Nine Months
02-07
MT
Transcript : Terumo Corporation, Q3 2024 Earnings Call, Feb 07, 2024
02-07
Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023
02-07
CI
Terumo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
02-07
CI
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
02-07
CI
Terumo Reacquires Over 500,000 Shares in January
02-05
MT
Terumo Repurchases Shares
01-10
MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.
01-09
CI
Jefferies Adjusts Terumo's Price Target to 5,300 Yen From 4,500 Yen, Keeps at Buy
01-04
MT
Hikaru Samejima to Assume Position as President and CEO of Terumo Corp. in April 2024
12-14
MT
Shinjiro Sato to Leave as CEO of Terumo Corporation on April 1, 2024
12-14
CI
Terumo Corporation Announces Management Changes, Effective from April 1, 2024
12-14
CI
Terumo Repurchases 629,300 Shares in November
12-05
MT
Transcript : Terumo Corporation, Q2 2024 Earnings Call, Nov 15, 2023
11-15
Japanese Shares Continue Winning Streak on Wednesday Amid Rising Hopes on US Rate-Hike Pause
11-15
MT
Japan's Nikkei jumps 2% on strong earnings, dovish Fed bets
11-15
RE
Terumo's Fiscal H1 Attributable Profit Climbs on Strong Infusion, Catheter Product Sales; Shares Surge 10%
11-15
MT
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
11-14
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
More about the company
Last Close Price
2,666
JPY
Average target price
2,951
JPY
Spread / Average Target
+10.66%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1